Similarly, it was reported that USH2 patients carrying the p.Glu767Serfs*21 USH2A mutation can have earlier diagnosis of disease, onset of night blindness, onset of visual field loss, diagnosis of cataract and onset of hearing loss than those carrying the p.Cys759Phe mutation27. Here, USH2A is linked to hearing loss disorder.